Boston Scientific Corporation (NYSE: BSX) announces the U.S. launch of its Charger™ PTA Balloon Catheter, a 0.035" percutaneous transluminal angioplasty (PTA) balloon catheter designed for a wide range of peripheral angioplasty procedures. The Charger PTA Balloon Catheter is Boston Scientific's third new peripheral balloon catheter introduced in 2011 and strengthens the Company's position as a global leader in peripheral angioplasty balloons.
The Charger PTA Balloon Catheter is designed for post-stent dilatation as well as conventional balloon angioplasty to open blocked peripheral arteries. It features high rated burst pressures (up to 20 ATM for selected sizes), rapid deflation, and a low lesion entry profile.
"The Charger PTA Balloon Catheter is designed to deliver results in both routine and challenging cases," said Jeff Mirviss, President of Boston Scientific's Peripheral Interventions Division. "With a low profile and tapered tip, it is engineered to provide excellent push without sacrificing track. The Charger PTA Balloon Catheter complements our growing portfolio of interventional devices for peripheral vasculature procedures."
The Charger PTA Balloon Catheter is compatible with a 6 Fr sheath for 10x80 mm balloons and is available in a broad range of sizes including 3-12 mm diameters and 20-200 mm lengths on 75 or 135 cm shafts.
New sprayable gel promises safer endoscopic surgeries